Human Growth Hormone Market By Indication (Prader-Willi Syndrome, Idiopathic Short Stature, Growth Hormone Deficiency, Turner Syndrome and Other Indications), Route Of Administration (Oral, Intramuscular, Intravenous and Subcutaneous) and Distribution Channel (Clinics, Online Pharmacy, Hospital Pharmacy and Retail Pharmacy) - Global Industry Analysis And Forecast To 2025

Published On : September 2018 Pages : 180 Category: Pharma & Healthcare Report Code : HC091281

Industry Outlook

Therefore, the Human Growth Hormone Market is anticipated to expand and has tremendous scope during the forecast period. The global Human Growth Hormone Market anticipated to flourish in the future by growing at a significantly higher CAGR. Human Growth Hormone (HGH) also referred to as somatotropin or simply Growth Hormone (GH), is a peptide hormone that is used for stimulating growth, cell regeneration & cell reproduction. Human Growth Hormone is synthesized, secreted & stored by somatotropin cells present in the anterior pituitary gland. Human Growth Hormone is an active agent present in many medications & also many other products available online. Use of Human Growth Hormone is growing due to; rising knowledge about the effectiveness of HGH, wide number of applications, increasing investment by many industries on R&D to develop a therapy with side-effects, development in the recombination HGH, etc.

Market Segmentation

The global Human Growth Hormone Market is based on segment, by Indication the market is segmented into Prader-Willi Syndrome, Idiopathic Short Stature, Growth Hormone Deficiency, Turner Syndrome and Other Indications, by Route Of Administration the market is segmented into Oral, Intramuscular, Intravenous and Subcutaneous, and by Distribution Channel the market is segmented into Clinics, Online Pharmacy, Hospital Pharmacy and Retail Pharmacy.

  • Human Growth Hormone Market, By Indication
  • Prader-Willi Syndrome
  • Idiopathic Short Stature
  • Growth Hormone Deficiency
  • Turner Syndrome
  • Other Indications
  • Human Growth Hormone Market, By Route Of Administration
  • Oral
  • Intramuscular
  • Intravenous
  • Subcutaneous
  • Human Growth Hormone Market, By Distribution Channel
  • Clinics
  • Online Pharmacy
  • Hospital Pharmacy
  • Retail Pharmacy

Regional Insights

On a global front, the Human Growth Hormone Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). North American region is leading the Human Growth Hormone Market owing to many key players present in the region & step by FDA to commercialize growth hormone in the region.

Human Growth Hormone Market, By Region

    • North America
  • U.S.
  • Canada
  • Mexico
    • Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
    • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia-Pacific
    • South America
  • Brazil
  • Argentina
  • Columbia
  • Rest of South America
    • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of MEA

Competitive Analysis

The leading players in the market are Anhui Anke Biotechnology (Group) Co. Ltd., GeneScience Pharmaceuticals Co. Ltd., Eli Lilly and Company, Merck KGaA, Biopartners GmbH, Roche Holdings Inc., Novartis AG, Novo Nordisk A/S, Pfizer Inc. and Ipsen S.A. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

  • Anhui Anke Biotechnology (Group) Co. Ltd
  • GeneScience Pharmaceuticals Co. Ltd.
  • Eli Lilly and Company
  • Merck KGaA
  • Biopartners GmbH
  • Roche Holdings Inc.
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Ipsen S.A

Some of the key questions answered by the report are:          

  • What was the market size in 2014 and forecast from 2015 to 2025?
  • What will be the industry market growth from 2015 to 2025?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

o   Human Growth Hormone Market, By Indication, Estimates and Forecast, 2014-2025 ($Million)

o   Prader-Willi Syndrome

o   Idiopathic Short Stature

o   Growth Hormone Deficiency

o   Turner Syndrome

o   Other Indications

o   Human Growth Hormone Market, By Route Of Administration, Estimates and Forecast, 2014-2025 ($Million)

o   Oral

o   Intramuscular

o   Intravenous

o   Subcutaneous

o   Human Growth Hormone Market, By Distribution Channel, Estimates and Forecast, 2014-2025 ($Million)

o   Clinics

o   Online Pharmacy

o   Hospital Pharmacy

o   Retail Pharmacy

Human Growth Hormone Market, By Region, Estimates and Forecast, 2014-2025 ($Million)

o   North America

§  North America Human Growth Hormone Market, By Country

o   U.S. Human Growth Hormone Market

o   Canada Human Growth Hormone Market

o   Mexico Human Growth Hormone Market

o   Europe

§  Europe Human Growth Hormone Market, By Country

o   Germany Human Growth Hormone Market

o   UK Human Growth Hormone Market

o   France Human Growth Hormone Market

o   Russia Human Growth Hormone Market

o   Italy Human Growth Hormone Market

o   Rest of Europe Human Growth Hormone Market

o   Asia-Pacific

§  Asia-Pacific Human Growth Hormone Market, By Country

o   China Human Growth Hormone Market

o   Japan Human Growth Hormone Market

o   South Korea  Human Growth Hormone Market

o   India Human Growth Hormone Market

o   Southeast Asia Human Growth Hormone Market

o   Rest of Asia-Pacific Human Growth Hormone Market

o   South America

§  South America Human Growth Hormone Market, By Country

o   Brazil Human Growth Hormone Market

o   Argentina Human Growth Hormone Market

o   Columbia Human Growth Hormone Market

o   Rest of South America Human Growth Hormone Market

o   Middle East and Africa

§  Middle East and Africa Human Growth Hormone Market, By Country

o   Saudi Arabia Human Growth Hormone Market

o   UAE Human Growth Hormone Market

o   Egypt Human Growth Hormone Market

o   Nigeria Human Growth Hormone Market

o   South Africa Human Growth Hormone Market

o   Rest of MEA Human Growth Hormone Market

Table of Contents

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2014-2025)

4.1.2.  Canada Market Status and Outlook (2014-2025)

4.1.3.  Mexico Market Status and Outlook (2014-2025)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2014-2025)

4.2.2.  France Market Status and Outlook (2014-2025)

4.2.3.  UK Market Status and Outlook (2014-2025)

4.2.4.  Russia Market Status and Outlook (2014-2025)

4.2.5.  Italy Market Status and Outlook (2014-2025)

4.2.6.  Rest of Europe Market Status and Outlook (2014-2025)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2014-2025)

4.3.2.  Japan Market Status and Outlook (2014-2025)

4.3.3.  Korea Market Status and Outlook (2014-2025)

4.3.4.  India Market Status and Outlook (2014-2025)

4.3.5.  Southeast Asia Market Status and Outlook (2014-2025)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2014-2025)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2014-2025)

4.4.2.  Argentina Market Status and Outlook (2014-2025)

4.4.3.  Columbia Market Status and Outlook (2014-2025)

4.4.4.  Rest of South America Market Status and Outlook (2014-2025)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2014-2025)

4.5.2.  United Arab Emirates Market Status and Outlook (2014-2025)

4.5.3.  Egypt Market Status and Outlook (2014-2025)

4.5.4.  Nigeria Market Status and Outlook (2014-2025)

4.5.5.  South Africa Market Status and Outlook (2014-2025)

4.5.6.  Turkey Market Status and Outlook (2014-2025)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2014-2025)

5.       Human Growth Hormone  Market, By Indication

5.1.     Introduction

5.2.     Global Human Growth Hormone  Revenue and Market Share by Indication (2014-2018)

5.2.1.  Global Human Growth Hormone  Revenue and Revenue Share by Indication (2014-2018)

5.3.     Prader-Willi Syndrome

5.3.1.  Global Prader-Willi Syndrome Revenue and Growth Rate (2014-2018)

5.4.     Idiopathic Short Stature

5.4.1.  Global Idiopathic Short Stature Revenue and Growth Rate (2014-2018)

5.5.     Growth Hormone Deficiency

5.5.1.  Global Growth Hormone Deficiency Revenue and Growth Rate (2014-2018)

5.6.     Turner Syndrome

5.6.1.  Global Turner Syndrome Revenue and Growth Rate (2014-2018)

5.7.     Other Indications

5.7.1.  Global Other Indications Revenue and Growth Rate (2014-2018)

6.       Human Growth Hormone  Market, By Route Of Administration

6.1.     Introduction

6.2.     Global Human Growth Hormone  Revenue and Market Share by Route Of Administration (2014-2018)

6.2.1.  Global Human Growth Hormone  Revenue and Revenue Share by Route Of Administration (2014-2018)

6.3.     Oral

6.3.1.  Global Oral Revenue and Growth Rate (2014-2018)

6.4.     Intramuscular

6.4.1.  Global Intramuscular  Revenue and Growth Rate (2014-2018)

6.5.     Intravenous

6.5.1.  Global Intravenous  Revenue and Growth Rate (2014-2018)

6.6.     Subcutaneous

6.6.1.  Global Subcutaneous Revenue and Growth Rate (2014-2018)

7.       Human Growth Hormone  Market, By Distribution Channel

7.1.     Introduction

7.2.     Global Human Growth Hormone  Revenue and Market Share by Distribution Channel (2014-2018)

7.2.1.  Global Human Growth Hormone  Revenue and Revenue Share by Distribution Channel (2014-2018)

7.3.     Clinics

7.3.1.  Global Clinics Revenue and Growth Rate (2014-2018)

7.4.     Online Pharmacy

7.4.1.  Global Online Pharmacy  Revenue and Growth Rate (2014-2018)

7.5.     Hospital Pharmacy

7.5.1.  Global Hospital Pharmacy  Revenue and Growth Rate (2014-2018)

7.6.     Retail Pharmacy

7.6.1.  Global Retail Pharmacy  Revenue and Growth Rate (2014-2018)

8.       Human Growth Hormone  Market, By Region

8.1.     Introduction

8.2.     Global Human Growth Hormone  Revenue and Market Share by Regions

8.2.1.  Global Human Growth Hormone  Revenue by Regions (2014-2018)

8.3.     North America Human Growth Hormone  by Countries

8.3.1.  North America Human Growth Hormone  Revenue and Growth Rate (2014-2018)

8.3.2.  North America Human Growth Hormone  Revenue (Million USD) by Countries (2014-2018)

8.3.3.  United States

8.3.3.1.  United States Human Growth Hormone  Revenue (Millions USD) and Growth Rate (2014-2018)

8.3.4.  Canada

8.3.4.1.  Canada Human Growth Hormone  Revenue (Millions USD) and Growth Rate (2014-2018)

8.3.5.  Mexico

8.3.5.1.  Mexico Human Growth Hormone  Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.     Europe Human Growth Hormone  by Countries

8.4.1.  Europe Human Growth Hormone  Revenue and Growth Rate (2014-2018)

8.4.2.  Europe Human Growth Hormone  Revenue (Million USD) by Countries (2014-2018)

8.4.3.  Germany

8.4.3.1.  Germany Human Growth Hormone  Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.4.  France

8.4.4.1.  France Human Growth Hormone  Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.5.  UK

8.4.5.1.  UK Human Growth Hormone  Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.6.  Russia

8.4.6.1.  Russia Human Growth Hormone  Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.7.  Italy

8.4.7.1.  Italy Human Growth Hormone  Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.8.  Rest of Europe

8.4.8.1.  Rest of Europe Human Growth Hormone  Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.     Asia-Pacific Human Growth Hormone  by Countries

8.5.1.  Asia-Pacific Human Growth Hormone  Revenue and Growth Rate (2014-2018)

8.5.2.  Asia-Pacific Human Growth Hormone  Revenue (Million USD) by Countries (2014-2018)

8.5.3.  China

8.5.3.1.  China Human Growth Hormone  Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.4.  Japan

8.5.4.1.  Japan Human Growth Hormone  Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.5.  Korea

8.5.5.1.  Korea Human Growth Hormone  Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.6.  India

8.5.6.1.  India Human Growth Hormone  Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.7.  Southeast Asia

8.5.7.1.  Southeast Asia Human Growth Hormone  Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.8.  Rest of Asia-Pacific

8.5.8.1.  Rest of Asia-Pacific Human Growth Hormone  Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.     South America Human Growth Hormone  by Countries

8.6.1.  South America Human Growth Hormone  Revenue and Growth Rate (2014-2018)

8.6.2.  South America Human Growth Hormone  Revenue (Million USD) by Countries (2014-2018)

8.6.3.  Brazil

8.6.3.1.  Brazil Human Growth Hormone  Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.4.  Argentina

8.6.4.1.  Argentina Human Growth Hormone  Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.5.  Columbia

8.6.5.1.  Columbia Human Growth Hormone  Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.6.  Rest of South America

8.6.6.1.  Rest of South America Human Growth Hormone  Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.     Middle East and Africa Human Growth Hormone  by Countries

8.7.1.  Middle East and Africa Human Growth Hormone  Revenue and Growth Rate (2014-2018)

8.7.2.  Middle East and Africa Human Growth Hormone  Revenue (Million USD) by Countries (2014-2018)

8.7.3.  Saudi Arabia

8.7.3.1.  Saudi Arabia Human Growth Hormone  Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.4.  United Arab Emirates

8.7.4.1.  United Arab Emirates Human Growth Hormone  Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.5.  Egypt

8.7.5.1.  Egypt Human Growth Hormone  Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.6.  Nigeria

8.7.6.1.  Nigeria Human Growth Hormone  Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.7.  South Africa

8.7.7.1.  South Africa Human Growth Hormone  Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.8.  Turkey

8.7.8.1.  Turkey Human Growth Hormone  Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.9.  Rest of Middle East and Africa

8.7.9.1.  Rest of Middle East and Africa Human Growth Hormone  Revenue (Millions USD) and Growth Rate (2014-2018)

9.       Company Profiles

9.1.     Anhui Anke Biotechnology (Group) Co. Ltd

9.1.1.  Business Overview

9.1.2.   Service Portfolio

9.1.3.  Strategic Developments

9.1.4.   Revenue and Market Share

9.2.     GeneScience Pharmaceuticals Co. Ltd.

9.2.1.  Business Overview

9.2.2.   Service Portfolio

9.2.3.  Strategic Developments

9.2.4.   Revenue and Market Share

9.3.     Eli Lilly and Company

9.3.1.  Business Overview

9.3.2.   Service Portfolio

9.3.3.  Strategic Developments

9.3.4.   Revenue and Market Share

9.4.     Merck KGaA

9.4.1.  Business Overview

9.4.2.   Service Portfolio

9.4.3.  Strategic Developments

9.4.4.   Revenue and Market Share

9.5.     Biopartners GmbH

9.5.1.  Business Overview

9.5.2.   Service Portfolio

9.5.3.  Strategic Developments

9.5.4.   Revenue and Market Share

9.6.     Roche Holdings Inc.

9.6.1.  Business Overview

9.6.2.   Service Portfolio

9.6.3.  Strategic Developments

9.6.4.   Revenue and Market Share

9.7.     Novartis AG

9.7.1.  Business Overview

9.7.2.   Service Portfolio

9.7.3.  Strategic Developments

9.7.4.   Revenue and Market Share

9.8.     Novo Nordisk A/S

9.8.1.  Business Overview

9.8.2.   Service Portfolio

9.8.3.  Strategic Developments

9.8.4.   Revenue and Market Share

9.9.     Pfizer Inc.

9.9.1.  Business Overview

9.9.2.   Service Portfolio

9.9.3.  Strategic Developments

9.9.4.   Revenue and Market Share

9.10. Ipsen S.A

9.10.1.      Business Overview

9.10.2.       Service Portfolio

9.10.3.      Strategic Developments

9.10.4.       Revenue and Market Share

10.    Global Human Growth Hormone  Market Competition, by Manufacturer

10.1. Global Human Growth Hormone  Revenue and Market Share by Manufacturer (2016-2017)

10.2. Global Human Growth Hormone  Price By Region (2016-2017)

10.3. Top 5 Human Growth Hormone  Manufacturer Market Share

10.4. Market Competition Trend

11.    Human Growth Hormone  Market Forecast (2018-2025)

11.1. Global Human Growth Hormone  Revenue (Millions USD) and Growth Rate (2018-2025)

11.2. Human Growth Hormone  Market Forecast by Regions (2018-2025)

11.2.1.      North America Human Growth Hormone  Market Forecast (2018-2025)

11.2.1.1. United States Human Growth Hormone  Market Forecast (2018-2025)

11.2.1.2. Canada Human Growth Hormone  Market Forecast (2018-2025)

11.2.1.3. Mexico Human Growth Hormone  Market Forecast (2018-2025)

11.2.2.      Europe Human Growth Hormone  Market Forecast (2018-2025)

11.2.2.1. Germany Human Growth Hormone  Market Forecast (2018-2025)

11.2.2.2. France Human Growth Hormone  Market Forecast (2018-2025)

11.2.2.3. UK Human Growth Hormone  Market Forecast (2018-2025)

11.2.2.4. Russia Human Growth Hormone  Market Forecast (2018-2025)

11.2.2.5. Italy Human Growth Hormone  Market Forecast (2018-2025)

11.2.2.6. Rest of Europe Human Growth Hormone  Market Forecast (2018-2025)

11.2.3.      Asia-Pacific Human Growth Hormone  Market Forecast (2018-2025)

11.2.3.1. China Human Growth Hormone  Market Forecast (2018-2025)

11.2.3.2. Japan Human Growth Hormone  Market Forecast (2018-2025)

11.2.3.3. Korea Human Growth Hormone  Market Forecast (2018-2025)

11.2.3.4. India Human Growth Hormone  Market Forecast (2018-2025)

11.2.3.5. Southeast Asia Human Growth Hormone  Market Forecast (2018-2025)

11.2.3.6. Rest of Asia-Pacific Human Growth Hormone  Market Forecast (2018-2025)

11.2.4.      South America Human Growth Hormone  Market Forecast (2018-2025)

11.2.4.1. Brazil Human Growth Hormone  Market Forecast (2018-2025)

11.2.4.2. Argentina Human Growth Hormone  Market Forecast (2018-2025)

11.2.4.3. Columbia Human Growth Hormone  Market Forecast (2018-2025)

11.2.4.4. Rest of South America Human Growth Hormone  Market Forecast (2018-2025)

11.2.5.      Middle East and Africa Human Growth Hormone  Market Forecast (2018-2025)

11.2.5.1. Saudi Arabia Human Growth Hormone  Market Forecast (2018-2025)

11.2.5.2. United Arab Emirates Human Growth Hormone  Market Forecast (2018-2025)

11.2.5.3. Egypt Human Growth Hormone  Market Forecast (2018-2025)

11.2.5.4. Nigeria Human Growth Hormone  Market Forecast (2018-2025)

11.2.5.5. South Africa Human Growth Hormone  Market Forecast (2018-2025)

11.2.5.6. Turkey Human Growth Hormone  Market Forecast (2018-2025)

11.2.5.7. Rest of Middle East and Africa Human Growth Hormone  Market Forecast (2018-2025)

11.3. Human Growth Hormone  Market Forecast by Indication (2018-2025)

11.3.1.      Human Growth Hormone  Forecast by Indication (2018-2025)

11.3.2.      Human Growth Hormone  Market Share Forecast by Indication (2018-2025)

11.4. Human Growth Hormone  Market Forecast by Route Of Administration (2018-2025)

11.4.1.      Human Growth Hormone  Forecast by Route Of Administration (2018-2025)

11.4.2.      Human Growth Hormone  Market Share Forecast by Route Of Administration (2018-2025)

11.5. Human Growth Hormone  Market Forecast by Distribution Channel (2018-2025)

11.5.1.      Human Growth Hormone  Forecast by Distribution Channel (2018-2025)

11.5.2.      Human Growth Hormone  Market Share Forecast by Distribution Channel (2018-2025)


List of Tables

List of Tables and Figures
Figure United States Human Growth Hormone Revenue (Million USD) and Growth Rate (2014-2025)
Figure Canada Human Growth Hormone Revenue (Million USD) and Growth Rate (2014-2025)
Figure Mexico Human Growth Hormone Revenue (Million USD) and Growth Rate (2014-2025)
Figure Germany Human Growth Hormone Revenue (Million USD) and Growth Rate (2014-2025)
Figure France Human Growth Hormone Revenue (Million USD) and Growth Rate (2014-2025)
Figure UK Human Growth Hormone Revenue (Million USD) and Growth Rate (2014-2025)
Figure Russia Human Growth Hormone Revenue (Million USD) and Growth Rate (2014-2025)
Figure Italy Human Growth Hormone Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Europe Human Growth Hormone Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Human Growth Hormone Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Human Growth Hormone Revenue (Million USD) and Growth Rate (2014-2025)
Figure Korea Human Growth Hormone Revenue (Million USD) and Growth Rate (2014-2025)
Figure India Human Growth Hormone Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia Human Growth Hormone Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Asia-Pacific Human Growth Hormone Revenue (Million USD) and Growth Rate (2014-2025)
Figure Brazil Human Growth Hormone Revenue (Million USD) and Growth Rate (2014-2025)
Figure Argentina Human Growth Hormone Revenue (Million USD) and Growth Rate (2014-2025)
Figure Columbia Human Growth Hormone Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of South America Human Growth Hormone Revenue (Million USD) and Growth Rate (2014-2025)
Figure Saudi Arabia Human Growth Hormone Revenue (Million USD) and Growth Rate (2014-2025)
Figure United Arab Emirates Human Growth Hormone Revenue (Million USD) and Growth Rate (2014-2025)
Figure Egypt Human Growth Hormone Revenue (Million USD) and Growth Rate (2014-2025)
Figure Nigeria Human Growth Hormone Revenue (Million USD) and Growth Rate (2014-2025)
Figure South Africa Human Growth Hormone Revenue (Million USD) and Growth Rate (2014-2025)
Figure Turkey Human Growth Hormone Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Middle East and Africa Human Growth Hormone Revenue (Million USD) and Growth Rate (2014-2025)
Table Global Human Growth Hormone Revenue and Revenue Share by Indication (2014-2018)
Figure Global Prader-Willi Syndrome Revenue and Growth Rate (2014-2018)
Figure Global Idiopathic Short Stature Revenue and Growth Rate (2014-2018)
Figure Global Growth Hormone Deficiency Revenue and Growth Rate (2014-2018)
Figure Global Turner Syndrome Revenue and Growth Rate (2014-2018)
Figure Global Other Indications Revenue and Growth Rate (2014-2018)
Table Global Human Growth Hormone Revenue and Revenue Share by Route Of Administration (2014-2018)
Figure Global Oral Revenue and Growth Rate (2014-2018)
Figure Global Intramuscular Revenue and Growth Rate (2014-2018)
Figure Global Intravenous Revenue and Growth Rate (2014-2018)
Figure Global Subcutaneous Revenue and Growth Rate (2014-2018)
Table Global Human Growth Hormone Revenue and Revenue Share by Distribution Channel (2014-2018)
Figure Global Clinics Revenue and Growth Rate (2014-2018)
Figure Global Online Pharmacy Revenue and Growth Rate (2014-2018)
Figure Global Hospital Pharmacy Revenue and Growth Rate (2014-2018)
Figure Global Retail Pharmacy Revenue and Growth Rate (2014-2018)
Table Global Human Growth Hormone Revenue by Regions (2014-2018)
Figure North America Human Growth Hormone Growth Rate (2014-2018)
Figure North America Human Growth Hormone Revenue and Growth Rate (2014-2018)
Figure North America Human Growth Hormone by Countries (2014-2018)
Figure North America Human Growth Hormone Revenue (Million USD) by Countries (2014-2018)
Figure United States Human Growth Hormone Growth Rate (2014-2018)
Figure United States Human Growth Hormone Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Canada Human Growth Hormone Growth Rate (2014-2018)
Figure Canada Human Growth Hormone Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Mexico Human Growth Hormone Growth Rate (2014-2018)
Figure Mexico Human Growth Hormone Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Europe Human Growth Hormone Growth Rate (2014-2018)
Figure Europe Human Growth Hormone Revenue and Growth Rate (2014-2018)
Figure Europe Human Growth Hormone by Countries (2014-2018)
Figure Europe Human Growth Hormone Revenue (Million USD) by Countries (2014-2018)
Figure Germany Human Growth Hormone Growth Rate (2014-2018)
Figure Germany Human Growth Hormone Revenue (Millions USD) and Growth Rate (2014-2018)
Figure France Human Growth Hormone Growth Rate (2014-2018)
Figure France Human Growth Hormone Revenue (Millions USD) and Growth Rate (2014-2018)
Figure UK Human Growth Hormone Growth Rate (2014-2018)
Figure UK Human Growth Hormone Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Russia Human Growth Hormone Growth Rate (2014-2018)
Figure Russia Human Growth Hormone Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Italy Human Growth Hormone Growth Rate (2014-2018)
Figure Italy Human Growth Hormone Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Europe Human Growth Hormone Growth Rate (2014-2018)
Figure Rest of Europe Human Growth Hormone Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Asia-Pacific Human Growth Hormone Growth Rate (2014-2018)
Figure Asia-Pacific Human Growth Hormone Revenue and Growth Rate (2014-2018)
Figure Asia-Pacific Human Growth Hormone by Countries (2014-2018)
Figure Asia-Pacific Human Growth Hormone Revenue (Million USD) by Countries (2014-2018)
Figure China Human Growth Hormone Growth Rate (2014-2018)
Figure China Human Growth Hormone Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Japan Human Growth Hormone Growth Rate (2014-2018)
Figure Japan Human Growth Hormone Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Korea Human Growth Hormone Growth Rate (2014-2018)
Figure Korea Human Growth Hormone Revenue (Millions USD) and Growth Rate (2014-2018)
Figure India Human Growth Hormone Growth Rate (2014-2018)
Figure India Human Growth Hormone Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Southeast Asia Human Growth Hormone Growth Rate (2014-2018)
Figure Southeast Asia Human Growth Hormone Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Human Growth Hormone Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Human Growth Hormone Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South America Human Growth Hormone Growth Rate (2014-2018)
Figure South America Human Growth Hormone Revenue and Growth Rate (2014-2018)
Figure South America Human Growth Hormone by Countries (2014-2018)
Figure South America Human Growth Hormone Revenue (Million USD) by Countries (2014-2018)
Figure Brazil Human Growth Hormone Growth Rate (2014-2018)
Figure Brazil Human Growth Hormone Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Argentina Human Growth Hormone Growth Rate (2014-2018)
Figure Argentina Human Growth Hormone Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Columbia Human Growth Hormone Growth Rate (2014-2018)
Figure Columbia Human Growth Hormone Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of South America Human Growth Hormone Growth Rate (2014-2018)
Figure Rest of South America Human Growth Hormone Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Middle East and Africa Human Growth Hormone Growth Rate (2014-2018)
Figure Middle East and Africa Human Growth Hormone Revenue and Growth Rate (2014-2018)
Figure Middle East and Africa Human Growth Hormone by Countries (2014-2018)
Figure Middle East and Africa Human Growth Hormone Revenue (Million USD) by Countries (2014-2018)
Figure Saudi Arabia Human Growth Hormone Growth Rate (2014-2018)
Figure Saudi Arabia Human Growth Hormone Revenue (Millions USD) and Growth Rate (2014-2018)
Figure United Arab Emirates Human Growth Hormone Growth Rate (2014-2018)
Figure United Arab Emirates Human Growth Hormone Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Egypt Human Growth Hormone Growth Rate (2014-2018)
Figure Egypt Human Growth Hormone Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Nigeria Human Growth Hormone Growth Rate (2014-2018)
Figure Nigeria Human Growth Hormone Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South Africa Human Growth Hormone Growth Rate (2014-2018)
Figure South Africa Human Growth Hormone Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Turkey Human Growth Hormone Growth Rate (2014-2018)
Figure Turkey Human Growth Hormone Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Human Growth Hormone Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Human Growth Hormone Revenue (Millions USD) and Growth Rate (2014-2018)
Table Anhui Anke Biotechnology (Group) Co. Ltd Human Growth Hormone Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GeneScience Pharmaceuticals Co. Ltd. Human Growth Hormone Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly and Company Human Growth Hormone Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck KGaA Human Growth Hormone Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biopartners GmbH Human Growth Hormone Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Holdings Inc. Human Growth Hormone Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis AG Human Growth Hormone Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novo Nordisk A/S Human Growth Hormone Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Inc. Human Growth Hormone Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ipsen S.A Human Growth Hormone Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Human Growth Hormone Market Share by Manufacturer
Figure Global Human Growth Hormone Revenue and Market Share by Manufacturer
Table Global Human Growth Hormone Price by Region (2016-2017)
Figure Top 5 Human Growth Hormone Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Human Growth Hormone Revenue (Millions USD) and Growth Rate (2018-2025)
Table Human Growth Hormone Market Forecast by Regions (2018-2025)
Figure North America Human Growth Hormone Market Forecast (2018-2025)
Figure United States Human Growth Hormone Market Forecast (2018-2025)
Figure Canada Human Growth Hormone Market Forecast (2018-2025)
Figure Mexico Human Growth Hormone Market Forecast (2018-2025)
Figure Europe Human Growth Hormone Market Forecast (2018-2025)
Figure Germany Human Growth Hormone Market Forecast (2018-2025)
Figure France Human Growth Hormone Market Forecast (2018-2025)
Figure UK Human Growth Hormone Market Forecast (2018-2025)
Figure Russia Human Growth Hormone Market Forecast (2018-2025)
Figure Italy Human Growth Hormone Market Forecast (2018-2025)
Figure Rest of Europe Human Growth Hormone Market Forecast (2018-2025)
Figure Asia-Pacific Human Growth Hormone Market Forecast (2018-2025)
Figure China Human Growth Hormone Market Forecast (2018-2025)
Figure Japan Human Growth Hormone Market Forecast (2018-2025)
Figure Korea Human Growth Hormone Market Forecast (2018-2025)
Figure India Human Growth Hormone Market Forecast (2018-2025)
Figure Southeast Asia Human Growth Hormone Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Human Growth Hormone Market Forecast (2018-2025)
Figure South America Human Growth Hormone Market Forecast (2018-2025)
Figure Brazil Human Growth Hormone Market Forecast (2018-2025)
Figure Argentina Human Growth Hormone Market Forecast (2018-2025)
Figure Columbia Human Growth Hormone Market Forecast (2018-2025)
Figure Rest of South America Human Growth Hormone Market Forecast (2018-2025)
Figure Middle East and Africa Human Growth Hormone Market Forecast (2018-2025)
Figure Saudi Arabia Human Growth Hormone Market Forecast (2018-2025)
Figure United Arab Emirates Human Growth Hormone Market Forecast (2018-2025)
Figure Egypt Human Growth Hormone Market Forecast (2018-2025)
Figure Nigeria Human Growth Hormone Market Forecast (2018-2025)
Figure South Africa Human Growth Hormone Market Forecast (2018-2025)
Figure Turkey Human Growth Hormone Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Human Growth Hormone Market Forecast (2018-2025)
Figure Global Human Growth Hormone Forecast by Indication (2018-2025)
Figure Global Human Growth Hormone Market Share Forecast by Indication (2018-2025)
Figure Global Human Growth Hormone Forecast by Indication (2018-2025)
Figure Global Human Growth Hormone Forecast by Route Of Administration (2018-2025)
Figure Global Human Growth Hormone Market Share Forecast by Route Of Administration (2018-2025)
Figure Global Human Growth Hormone Forecast by Route Of Administration (2018-2025)
Figure Global Human Growth Hormone Forecast by Distribution Channel (2018-2025)
Figure Global Human Growth Hormone Market Share Forecast by Distribution Channel (2018-2025)
Figure Global Human Growth Hormone Forecast by Distribution Channel (2018-2025)


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*